KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children
| Status: | Terminated |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | Any - 3 |
| Updated: | 1/12/2019 |
| Start Date: | July 3, 2018 |
| End Date: | October 18, 2018 |
Safety and Efficacy of KPI-121 1% Ophthalmic Suspension Versus Prednisolone Acetate Ophthalmic Suspension 1% for the Treatment of Inflammation Following Cataract Surgery in Children 0 to 3 Years of Age
This study is designed to assess how KPI-121 1% compares to prednisolone acetate in reducing
inflammation after cataract surgery in young children. Approximately half the participants
will receive KPI-121 1% eye drops and the other half will receive prednisolone acetate.
inflammation after cataract surgery in young children. Approximately half the participants
will receive KPI-121 1% eye drops and the other half will receive prednisolone acetate.
Inclusion Criteria:
- Be a candidate for routine, uncomplicated cataract surgery
Exclusion Criteria:
- Have a post-traumatic cataract.
- Have suspected permanent low vision or blindness in the fellow non-study eye.
- Have active uveitis in either eye.
- Have an ocular neoplasm in either eye.
- Have the presence of viral, bacterial, or fungal disease in either eye.
- Have glaucoma, ocular hypertension, steroid-induced IOP rise or elevated IOP
We found this trial at
4
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials